Jane R Connor

Title: Jane R Connor: Innovator in Cancer Treatment

Introduction

Jane R Connor is a prominent inventor based in University City, MO (US). She has made significant contributions to the field of cancer treatment, holding 2 patents that focus on innovative therapeutic methods. Her work is particularly relevant in the context of chemoprevention and treatment of various cancers.

Latest Patents

Among her latest patents, Connor has developed inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers. This patent describes agents and methods that include a selective inhibitor of inducible nitric oxide synthase, which can be combined with an inhibitor of cyclooxygenase-2 in a pharmaceutical composition. These agents are utilized for the chemoprevention and treatment of neoplasia, including colorectal cancer and other cancers affecting epithelial cells throughout the body. Additionally, her work addresses the treatment of fibrosis that occurs with radiation therapy and adenomatous polyps, particularly in cases of familial adenomatous polyposis (FAP). Another significant patent involves methods of treating osteoarthritis using inducible nitric oxide synthase inhibitors, providing a therapeutic approach to managing this condition.

Career Highlights

Throughout her career, Jane R Connor has worked with notable organizations, including Pharmacia Corporation. Her innovative research and development efforts have positioned her as a key figure in the medical and pharmaceutical fields.

Collaborations

Connor has collaborated with esteemed colleagues, including Pamela T Manning and Karen Seibert, contributing to the advancement of her research and the development of her patents.

Conclusion

Jane R Connor's contributions to cancer treatment and her innovative patents highlight her role as a leading inventor in the medical field. Her work continues to impact the lives of many patients facing serious health challenges.